India’s pace of vaccinations has become a source of global concern as its outbreak devastates the nation and spreads into neighboring countries, and as a variant first identified there begins to be found around the world. The outbreak has prompted India to keep vaccine doses produced by its large drug manufacturing industry at home instead of exporting them, slowing down vaccination campaigns elsewhere. But that has left state governments competing with one another for doses, and experts say it has added more troubles to a sluggish rollout. About 3 percent of India’s population has been fully vaccinated, and 9.2 percent of people have received at least one dose. India has recorded 20.6 million coronavirus cases and more than 226,000 deaths, according to a New York Times database.

Source: New York Times May 06, 2021 12:13 UTC